USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
29-Sep-2015
Global
Technology Research
D65E-01-00-00-00
MX0150-GL-TR_18357
Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets, is playing a crucial role in the pharmaceutical industry. This trend shows the strong focus of top biopharmaceutical companies in biologics, including monoclonal antibody therapeutics. This research service discusses the emerging trends in monoclonal antibody therapeutics on a global scale, through a detailed strategic assessment of the industry environment.
Research Scope
Research Methodology
Key Findings
Technology Snapshot – Multiple Segmentation
Industry Overview – Main Innovations
Industry Overview – Main Innovators
Technology Roadmap Toward Precision Medicine
Therapeutic Areas and Clinical Indications
Molecular Agents and Cell Targets
Developmental Stage Focus
Market Potential
Market Evolution
Venture Capital Investment
Company Stage Investment Focus
Government Funding and Support
Worldwide Landscape
Key Drivers and Restraints
Key Technical and Business Challenges
Industry Assessment – Partnerships and Alliances
Stakeholder Assessment for Partnerships
Partnerships and Alliances Models
Partnerships and Collaborations
Partnerships and Collaborations (continued)
Partnerships and Collaborations (continued)
Patent Analysis
Patent publishing trends
Patent office-wise distribution
R&D Success and Key Performance Indicators
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Contacts
Contacts (continued)
Strategic R&D Pipeline – The Road Ahead
R&D Pipeline Assessment
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
Product Line Assessment
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Abbreviations
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Cecilia Van Cauwenberghe |
| Industries | Healthcare |
| WIP Number | D65E-01-00-00-00 |
| Is Prebook | No |
Advances in monoclonal antibody therapeutics
$4,950.00
Special Price $3,712.50 save 25 %